Kindred teams with Omnicare, splits with skilled nursing pharmacy PharMerica

Share this article:
Kindred CEO Paul Diaz
Kindred CEO Paul Diaz

Major long-term care provider Kindred Healthcare will split with its current pharmacy partner, PharMerica, and team with the sector's largest pharmacy, Omnicare, at the end of 2013, according to documents filed with the Securities and Exchange Commission.

Form 8-K documents filed June 21 confirmed that Kindred will not renew its PharMerica contract for skilled nursing services after it lapses on Dec. 31, 2013. Under a separate contract, PharMerica will continue to provide pharmacy management for Kindred hospitals through 2014.

The SNF deal suggests Omnicare may take over Kindred's hospital contract in 2015, according to some observers.

Kindred's nursing facilities accounted for 11.5% of PharMerica's revenue in 2012, according to the pharmacy's annual report. Upon news of the contract loss, PharMerica share prices slid, and a Bank of America analyst lowered the price target on the company from $18 to $17. Market experts estimate the company will take “a hit” of $29 million next year. However, the company will also have lower costs by not serving Kindred, the analyst wrote, preserving the company's “buy” rating.

This is just the latest setback for PharMerica, which lost other major contracts when Golden Living created pharmaceutical services company AlixaRx last fall. Earlier in 2012, the Federal Trade Commission stepped in to block Omnicare's $441 million unsolicited takeover bid for PharMerica. Omnicare's offer undervalued PharMerica, PharMerica CEO Gregory Weishar said at the time.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.